organ transplant recipients
Herpesvirus Infections in Organ Transplant Recipients
... in organ transplantation in the last four decades, herpesvirus infections remain a major cause of morbidity and mortality for a majority of transplant ...of organ rejection, they have not restored ...
7
Influenza Prevention in Solid Organ Transplant Recipients: An Ongoing Challenge
... allograft recipients, adjuvant vaccination showed an association with increased rejection ...renal transplant patients that adjuvants were safe to use and had the same immunogenicity as the non- adjuvant ...
6
Skin carcinomas in organ-transplant recipients: from early oncogenic events to therapy
... the organ-transplant re- cipients than in controls, but the difference was not statistically significant and the den- sity in organ-transplant recipients was still extremely ...
104
Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid organ transplant recipients
... Comparison of PCR and pp65 Antigenemia Assay with Quantitative Shell Vial Culture for Detection of Cytomegalovirus in Blood Leukocytes from Solid-Organ Transplant Recipients GREGORY A.. [r] ...
7
Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients
... Solid Organ Transplant recipients (SOTR) was held at the University Hospital Virgen del Rocío, Seville, Spain with the aim to evaluate the ...
9
The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumanniiinfection
... solid organ trans- plant recipients is an additional concern ...liver transplant recipients ...solid organ transplant recipients and on its impact on the survival of these ...
8
Safety and Immunogenicity of the American Academy of Pediatrics–Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients
... solid organ transplant recipients (ie, heart, double- lung, heart-lung, liver, small bowel, multiple abdominal organs) between 2 and 18 years of age followed at the Children’s Hospital of Pittsburgh ...
10
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1 2: study protocol for a multicenter, randomized, controlled clinical trial
... Solid organ transplant recipients (liver, kidney, heart or lung), older than 16 years of age more than 30 days after transplantation were eligible to ...of organ and time after transplantation ...
10
Monitoring of Cytomegalovirus Infection in Solid Organ Transplant Recipients by an Ultrasensitive Plasma PCR Assay
... solid-organ transplant recipients (SOTR) and has a significant impact on transplant outcome (3, 25, 26, ...of transplant patients ...
8
Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High Throughput Automated Systems
... solid organ transplant recipients (9 male and 7 female; including 10 liver, 3 kidney, 2 heart, and 1 pancreas transplant recipients) with CMV viremia defined by the isolation of CMV ...
5
Serologic Evidence for Reactivation of Cryptococcosis in Solid-Organ Transplant Recipients
... Study population. Subjects included in the study were identified from a larger cohort of organ transplant recipients with cryptococcosis in a prospective study (12). Cryptococcosis was defined as ...
5
Epidemiogic aspects of skin cancer in organ-transplant recipients
... in organ-transplant recipients (OTR) due to long-term use of immunosuppressive drugs has been frequently reported ...heart-transplant recipients and 52% of the 121 ...
200
Traumatic Stress Symptoms in Adolescent Organ Transplant Recipients
... again. Transplant recipients who expressed interest in the study and those who had not declined after a 2-week period were contacted by ...outpatient transplant clinics for patient and family conve- ...
7
Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients
... National Organ Transplant Registry, PHARMO Institute for Drug Outcomes Research, Routine Outcome Moni- toring, and the Dutch Institute of Clinical Auditing data- base through a generic ...
13
Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series
... solid organ transplant; HES, Hospital Episodes Statistics database; CPRD, Clinical Practice Research Datalink; SCCS, self-controlled case series; A/H1N1pdm09, AS03 adjuvanted A/California/7/2009 like strain ...
10
Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea
... The genomic DNA of human cytomegalovirus (HCMV) can be incorporated into the host chromosome after pri- mary acquisition, usually in early life, and be retained in a latent form throughout life [1–4]. The complicated ...
7
Influenza B Virus Infection in Pediatric Solid Organ Transplant Recipients
... idemic infection in normal children, but only one case of infection in an immunocompromised solid organ transplant (SOT) recipient has been reported. Charac- terization of the clinical c[r] ...
7
Cladophialophora bantiana Brain Abscess in a Solid Organ Transplant Recipient: Case Report and Review of the Literature
... The site of fungal entry is not well understood for solid- organ transplant recipients with cerebral phaeohyphomycosis. Hematogenous dissemination from a pulmonary source is one possibility. In the ...
5
Automated Extraction and Quantification of Human Cytomegalovirus DNA in Whole Blood by Real Time PCR Assay
... FIG 2. Monitoring the HCMV load in WB and the PBL of five solid organ transplant recipients (SOT-1 to SOT-5) by using real-time Light Cycler PCR. The results of serial samples collected from five ...
6
Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
... This trial represents the long-term results of the first randomized trial comparing VGC to IV GCV for the treatment of CMV disease in organ transplant recipients. It further supports the findings of ...
11